113 results
S-3ASR
EX-4.5
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
Warrants for the number of Warrant Securities remaining unexercised.
(d) The Company shall not be required to pay any stamp or other tax or other … is involved, the Company shall not be required to issue or deliver any Warrant Security until such tax or other charge shall have been paid or it has
S-3ASR
EX-1.2
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
and franchise tax returns or have properly requested extensions thereof, except where the failure to so file would not reasonably be expected, individually … and franchise taxes for all periods as to which the tax liability of the Company or any of its subsidiaries has not been finally determined, except
S-3ASR
EX-4.3
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
Securityholder that is not a “United States person” for federal tax purposes;
(26) any restrictions on transfer, sale or assignment of the Securities … , and for a like aggregate principal amount, upon payment of a sum sufficient to cover any tax or other governmental charge in relation thereto, all
S-3ASR
IMVT
Immunovant Inc
9 Nov 23
Automatic shelf registration
8:49am
prices or rates and in the securities or other property receivable upon conversion or exchange; and
material or special U.S. federal income tax … material or special U.S. federal income tax considerations applicable to the preferred stock;
the relative ranking and preferences of the preferred
S-3ASR
EX-4.6
xpokb4iztt8tp3jfdntq
9 Nov 23
Automatic shelf registration
8:49am
S-3ASR
EX-4.7
xe2ci6h zjwv5zy2oh
9 Nov 23
Automatic shelf registration
8:49am
424B5
tpu4a5y9hm0tf jp
29 Sep 23
Prospectus supplement for primary offering
4:48pm
8-K
EX-1.1
7oqh fhhm
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-10.1
hecn58zu
28 Sep 23
Entry into a Material Definitive Agreement
5:23pm
424B5
dra1m4zz64ju 6b
26 Sep 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
u3ba 9mh4nzdk
22 May 23
Results of Operations and Financial Condition
7:03am
424B5
b1ywn1 let
5 Oct 22
Prospectus supplement for primary offering
4:43pm
8-K
EX-1.1
xvc60 omr9a
4 Oct 22
Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
5:28pm